Literature DB >> 25449564

Continuous epidural infusion anesthesia and analgesia in gynecologic oncology patients: less pain, more gain?

Madeleine Courtney-Brooks1, Kirby C Tanner Kurtz2, Elizabeth B Pelkofski2, John Nakayama2, Linda R Duska2.   

Abstract

OBJECTIVE: There is a lack of consistent data regarding gynecologic oncology (GO) patients and the use of neuraxial anesthesia for post-operative pain management. Our objective was to compare the use of continuous epidural infusion (CEI) as part of post-operative pain management to more traditional management schemes.
METHODS: GO patients undergoing laparotomy from July 1st, 2011 through July 31st, 2012 were identified. Patient demographic data and peri-operative details were abstracted from the medical record. The primary outcome was a mean patient visual analog pain score. Secondary outcomes included length of stay, post-operative urinary tract infection (UTI) and venous thromboembolic (VTE) events.
RESULTS: There were 237 laparotomies during the study time period. Fifty-six women had CEI for post-operative pain management and 181 did not. Patients with CEI had lower pain scores on POD #0 (3.8 vs 5.3, p < 0.01), #1 (2.6 vs 4.0, p < 0.01) and #2 (2.5 vs 3.5, p < 0.01) compared to women without CEI. There was no difference in the length of stay between those with and without CEI (103 vs 94 h, p = 0.32). Women with CEI did have a longer length of urinary catheterization (56 vs 26 h, p = 0.01) but not an increased rate of UTI (5.5% vs 1.8%, p = 0.24). There was a higher rate of post-operative VTE events among women with CEI (8.9% vs 1.7%, p = 0.02).
CONCLUSIONS: In this small series, GO patients undergoing laparotomy had improved post-operative pain control when their analgesia regimen included CEI. However, the higher rate of VTE events among CEI users is concerning and merits further investigation.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epidural analgesia; Gynecologic oncology; Laparotomy

Mesh:

Year:  2014        PMID: 25449564     DOI: 10.1016/j.ygyno.2014.10.015

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  3 in total

1.  Effectiveness and safety of expanded perioperative thromboprophylaxis in complex gynecologic surgery.

Authors:  Bradley R Corr; Andrea M Winter; Mary D Sammel; Christina S Chu; Brian F Gage; Andrea R Hagemann
Journal:  Gynecol Oncol       Date:  2015-07-14       Impact factor: 5.482

2.  Guidelines for postoperative care in gynecologic/oncology surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations--Part II.

Authors:  G Nelson; A D Altman; A Nick; L A Meyer; P T Ramirez; C Achtari; J Antrobus; J Huang; M Scott; L Wijk; N Acheson; O Ljungqvist; S C Dowdy
Journal:  Gynecol Oncol       Date:  2016-01-03       Impact factor: 5.482

3.  Improved Postoperative Pain Control for Cytoreductive Surgery in Women With Ovarian Cancer Using Patient-Controlled Epidural Analgesia.

Authors:  Tak Kyu Oh; Myong Cheol Lim; Yumi Lee; Jung Yeon Yun; Seungmin Yeon; Sang-Yoon Park
Journal:  Int J Gynecol Cancer       Date:  2016-03       Impact factor: 3.437

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.